: Declining reimbursements and the high cost of shifting to Value-Based Care (VBC) models make the financial backing of a large firm attractive. 3. The Impact: Cost, Quality, and Autonomy
: Firms centralize "back-office" functions (billing, HR, payroll), allowing doctors to focus theoretically on clinical care.
: Most deals are now "bolt-ons"—small practices acquired to expand existing large platforms—which often fall below federal reporting thresholds, leading to "stealth consolidation". 2. The Driver: Why Doctors are Selling private equity firms buying medical practices
: PE provides the funds needed to upgrade electronic medical record (EMR) systems and invest in advanced diagnostic tools.
This feature explores the evolving landscape of private equity (PE) acquisitions in the medical sector as of 2026. : Declining reimbursements and the high cost of
After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management.
: While primary care was the early focus, firms are now aggressively targeting high-margin specialties including dermatology, ophthalmology, gastroenterology, and orthopedics. : Most deals are now "bolt-ons"—small practices acquired
Physicians are increasingly seeking PE partnerships to navigate a complex modern landscape: